WaveMan
WaveMan · Form 4
George F Tidmarsh insider trades
> Search tickers & screens ⌘K
LIVE

George F Tidmarsh insider trades

George F Tidmarsh has filed 11 Form 4s with the SEC that we hold, all for Revelation Biosciences, INC. (REVB), as Director. Across all of them we count 8 purchases worth $303.8K and 7 sales worth $42.8K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 42,100 shares of Revelation Biosciences, INC. worth $109.9K, dated 2022-02-07. The first filing on our record is dated 2022-02-09 and the latest 2025-02-13.

Revelation Biosciences, INC. (REVB)

Director · 11 filings · 15 purchases and sales
Trade dateCodeSharesValue as filedFiledSource
2022-02-04P, purchase reported on Form 42,000$4.9K2022-02-09SEC
2022-02-04P, purchase reported on Form 47,900$18.2K2022-02-09SEC
2022-02-07P, purchase reported on Form 442,100$109.9K2022-02-09SEC
2022-02-08P, purchase reported on Form 41,000$2.5K2022-02-10SEC
2022-02-09P, purchase reported on Form 430,000$76.5K2022-02-10SEC
2022-02-25P, purchase reported on Form 420,000$32.0K2022-02-28SEC
2023-04-17P, purchase reported on Form 426,500$30.7K2023-04-19SEC
2023-04-18P, purchase reported on Form 425,000$29.0K2023-04-19SEC
2023-09-14S, sale reported on Form 412,000$9.0K2023-09-18SEC
2023-09-15S, sale reported on Form 49,500$6.9K2023-09-18SEC
2023-09-18S, sale reported on Form 44,000$3.0K2023-09-18SEC
2023-09-28S, sale reported on Form 41,429$9862023-10-02SEC
2023-10-16S, sale reported on Form 41,845$1.2K2023-10-18SEC
2023-10-16S, sale reported on Form 410,957$7.2K2023-10-17SEC
2023-12-08S, sale reported on Form 427,771$14.4K2023-12-12SEC
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1287235) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-27 · For informational purposes only, not investment advice.
Privacy · Terms